161 related articles for article (PubMed ID: 15607126)
1. Long-term oral n-acetylcysteine reduces exhaled hydrogen peroxide in stable COPD.
De Benedetto F; Aceto A; Dragani B; Spacone A; Formisano S; Pela R; Donner CF; Sanguinetti CM
Pulm Pharmacol Ther; 2005; 18(1):41-7. PubMed ID: 15607126
[TBL] [Abstract][Full Text] [Related]
2. Increased hydrogen peroxide concentration in the exhaled breath condensate of stable COPD patients after nebulized N-acetylcysteine.
Rysz J; Stolarek RA; Luczynski R; Sarniak A; Wlodarczyk A; Kasielski M; Nowak D
Pulm Pharmacol Ther; 2007; 20(3):281-9. PubMed ID: 16753318
[TBL] [Abstract][Full Text] [Related]
3. Long-term administration of N-acetylcysteine decreases hydrogen peroxide exhalation in subjects with chronic obstructive pulmonary disease.
Kasielski M; Nowak D
Respir Med; 2001 Jun; 95(6):448-56. PubMed ID: 11421501
[TBL] [Abstract][Full Text] [Related]
4. Effect of inhaled N-acetylcysteine on hydrogen peroxide exhalation in healthy subjects.
Szkudlarek U; Zdziechowski A; Witkowski K; Kasielski M; Luczyńska M; Luczyński R; Sarniak A; Nowak D
Pulm Pharmacol Ther; 2004; 17(3):155-62. PubMed ID: 15123225
[TBL] [Abstract][Full Text] [Related]
5. Increased content of thiobarbituric acid-reactive substances and hydrogen peroxide in the expired breath condensate of patients with stable chronic obstructive pulmonary disease: no significant effect of cigarette smoking.
Nowak D; Kasielski M; Antczak A; Pietras T; Bialasiewicz P
Respir Med; 1999 Jun; 93(6):389-96. PubMed ID: 10464820
[TBL] [Abstract][Full Text] [Related]
6. Oxidative stress levels in exhaled breath condensate associated with COPD and smoking.
Inonu H; Doruk S; Sahin S; Erkorkmaz U; Celik D; Celikel S; Seyfikli Z
Respir Care; 2012 Mar; 57(3):413-9. PubMed ID: 21968597
[TBL] [Abstract][Full Text] [Related]
7. Validation of a new technique to assess exhaled hydrogen peroxide: results from normals and COPD patients.
De Benedetto F; Aceto A; Dragani B; Spacone A; Formisano S; Cocco R; Sanguinetti CM
Monaldi Arch Chest Dis; 2000 Jun; 55(3):185-8. PubMed ID: 10948662
[TBL] [Abstract][Full Text] [Related]
8. The effect of different treatment modalities on oxidative stress in COPD.
Kuleci S; Hanta I; Kocabas A; Canacankatan N
Adv Ther; 2008 Jul; 25(7):710-7. PubMed ID: 18592146
[TBL] [Abstract][Full Text] [Related]
9. Twice daily N-acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double-blind placebo-controlled trial.
Zheng JP; Wen FQ; Bai CX; Wan HY; Kang J; Chen P; Yao WZ; Ma LJ; Li X; Raiteri L; Sardina M; Gao Y; Wang BS; Zhong NS;
Lancet Respir Med; 2014 Mar; 2(3):187-94. PubMed ID: 24621680
[TBL] [Abstract][Full Text] [Related]
10. [The monitoring and its clinical significance of the hydrogen peroxide and interleukin-6 levels in exhaled breath condensate of chronic obstructive pulmonary diseases patients undergoing mechanical ventilation].
Yang GH; Wang GF
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2010 Aug; 22(8):455-8. PubMed ID: 20804645
[TBL] [Abstract][Full Text] [Related]
11. Variability of exhaled hydrogen peroxide in stable COPD patients and matched healthy controls.
van Beurden WJ; Dekhuijzen PN; Harff GA; Smeenk FW
Respiration; 2002; 69(3):211-6. PubMed ID: 12097763
[TBL] [Abstract][Full Text] [Related]
12. Increased exhalation of hydrogen peroxide in patients with stable and unstable chronic obstructive pulmonary disease.
Dekhuijzen PN; Aben KK; Dekker I; Aarts LP; Wielders PL; van Herwaarden CL; Bast A
Am J Respir Crit Care Med; 1996 Sep; 154(3 Pt 1):813-6. PubMed ID: 8810624
[TBL] [Abstract][Full Text] [Related]
13. Fluticasone and N-acetylcysteine in primary care patients with COPD or chronic bronchitis.
Schermer T; Chavannes N; Dekhuijzen R; Wouters E; Muris J; Akkermans R; van Schayck O; van Weel C
Respir Med; 2009 Apr; 103(4):542-51. PubMed ID: 19138505
[TBL] [Abstract][Full Text] [Related]
14. Exhaled nitric oxide and hydrogen peroxide in patients with chronic obstructive pulmonary disease: effects of inhaled beclomethasone.
Ferreira IM; Hazari MS; Gutierrez C; Zamel N; Chapman KR
Am J Respir Crit Care Med; 2001 Sep; 164(6):1012-5. PubMed ID: 11587988
[TBL] [Abstract][Full Text] [Related]
15. Fractionated exhaled breath condensate collection shows high hydrogen peroxide release in the airways.
Möller W; Heimbeck I; Weber N; Khadem Saba G; Körner B; Neiswirth M; Kohlhäufl M
J Aerosol Med Pulm Drug Deliv; 2010 Jun; 23(3):129-35. PubMed ID: 20073556
[TBL] [Abstract][Full Text] [Related]
16. Melatonin reduces lung oxidative stress in patients with chronic obstructive pulmonary disease: a randomized, double-blind, placebo-controlled study.
de Matos Cavalcante AG; de Bruin PF; de Bruin VM; Nunes DM; Pereira ED; Cavalcante MM; Andrade GM
J Pineal Res; 2012 Oct; 53(3):238-44. PubMed ID: 22507631
[TBL] [Abstract][Full Text] [Related]
17. Oral N-acetylcysteine attenuates pulmonary emphysema and alveolar septal cell apoptosis in smoking-induced COPD in rats.
Cai S; Chen P; Zhang C; Chen JB; Wu J
Respirology; 2009 Apr; 14(3):354-9. PubMed ID: 19341424
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological investigation on the anti-oxidant and anti-inflammatory activity of N-acetylcysteine in an ex vivo model of COPD exacerbation.
Cazzola M; Calzetta L; Facciolo F; Rogliani P; Matera MG
Respir Res; 2017 Jan; 18(1):26. PubMed ID: 28118826
[TBL] [Abstract][Full Text] [Related]
19. Hydrogen peroxide and nitrite reduction in exhaled breath condensate of COPD patients.
Stefanska J; Sarniak A; Wlodarczyk A; Sokolowska M; Doniec Z; Bialasiewicz P; Nowak D; Pawliczak R
Pulm Pharmacol Ther; 2012 Oct; 25(5):343-8. PubMed ID: 22705948
[TBL] [Abstract][Full Text] [Related]
20. Exhaled breath condensate in pulmonary arterial hypertension.
Warwick G; Kotlyar E; Chow S; Thomas PS; Yates DH
J Breath Res; 2012 Sep; 6(3):036006. PubMed ID: 22854169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
